Cargando…

Extended 6-Month Follow-Up of A Randomized Clinical Trial to Assess the Efficacy and Safety of Real-Time Continuous Glucose Monitoring in the Management of Type 1 Diabetes in Young Children Aged 4 to <10 Years

Detalles Bibliográficos
Autores principales: Tansey, Michael, Weinzimer, Stuart, Beck, Roy, Ruedy, Katrina, Cheng, Peiyao, Tamborlane, William, Kollman, Craig, Mauras, Nelly, Fox, Larry, Coffey, Julie, White, Neil H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3631880/
https://www.ncbi.nlm.nih.gov/pubmed/23613604
http://dx.doi.org/10.2337/dc12-2021
_version_ 1782266823295631360
author Tansey, Michael
Weinzimer, Stuart
Beck, Roy
Ruedy, Katrina
Cheng, Peiyao
Tamborlane, William
Kollman, Craig
Mauras, Nelly
Fox, Larry
Coffey, Julie
White, Neil H.
author_facet Tansey, Michael
Weinzimer, Stuart
Beck, Roy
Ruedy, Katrina
Cheng, Peiyao
Tamborlane, William
Kollman, Craig
Mauras, Nelly
Fox, Larry
Coffey, Julie
White, Neil H.
author_sort Tansey, Michael
collection PubMed
description
format Online
Article
Text
id pubmed-3631880
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-36318802014-05-01 Extended 6-Month Follow-Up of A Randomized Clinical Trial to Assess the Efficacy and Safety of Real-Time Continuous Glucose Monitoring in the Management of Type 1 Diabetes in Young Children Aged 4 to <10 Years Tansey, Michael Weinzimer, Stuart Beck, Roy Ruedy, Katrina Cheng, Peiyao Tamborlane, William Kollman, Craig Mauras, Nelly Fox, Larry Coffey, Julie White, Neil H. Diabetes Care Online Letters: Observations American Diabetes Association 2013-05 2013-04-13 /pmc/articles/PMC3631880/ /pubmed/23613604 http://dx.doi.org/10.2337/dc12-2021 Text en © 2013 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
spellingShingle Online Letters: Observations
Tansey, Michael
Weinzimer, Stuart
Beck, Roy
Ruedy, Katrina
Cheng, Peiyao
Tamborlane, William
Kollman, Craig
Mauras, Nelly
Fox, Larry
Coffey, Julie
White, Neil H.
Extended 6-Month Follow-Up of A Randomized Clinical Trial to Assess the Efficacy and Safety of Real-Time Continuous Glucose Monitoring in the Management of Type 1 Diabetes in Young Children Aged 4 to <10 Years
title Extended 6-Month Follow-Up of A Randomized Clinical Trial to Assess the Efficacy and Safety of Real-Time Continuous Glucose Monitoring in the Management of Type 1 Diabetes in Young Children Aged 4 to <10 Years
title_full Extended 6-Month Follow-Up of A Randomized Clinical Trial to Assess the Efficacy and Safety of Real-Time Continuous Glucose Monitoring in the Management of Type 1 Diabetes in Young Children Aged 4 to <10 Years
title_fullStr Extended 6-Month Follow-Up of A Randomized Clinical Trial to Assess the Efficacy and Safety of Real-Time Continuous Glucose Monitoring in the Management of Type 1 Diabetes in Young Children Aged 4 to <10 Years
title_full_unstemmed Extended 6-Month Follow-Up of A Randomized Clinical Trial to Assess the Efficacy and Safety of Real-Time Continuous Glucose Monitoring in the Management of Type 1 Diabetes in Young Children Aged 4 to <10 Years
title_short Extended 6-Month Follow-Up of A Randomized Clinical Trial to Assess the Efficacy and Safety of Real-Time Continuous Glucose Monitoring in the Management of Type 1 Diabetes in Young Children Aged 4 to <10 Years
title_sort extended 6-month follow-up of a randomized clinical trial to assess the efficacy and safety of real-time continuous glucose monitoring in the management of type 1 diabetes in young children aged 4 to <10 years
topic Online Letters: Observations
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3631880/
https://www.ncbi.nlm.nih.gov/pubmed/23613604
http://dx.doi.org/10.2337/dc12-2021
work_keys_str_mv AT tanseymichael extended6monthfollowupofarandomizedclinicaltrialtoassesstheefficacyandsafetyofrealtimecontinuousglucosemonitoringinthemanagementoftype1diabetesinyoungchildrenaged4to10years
AT weinzimerstuart extended6monthfollowupofarandomizedclinicaltrialtoassesstheefficacyandsafetyofrealtimecontinuousglucosemonitoringinthemanagementoftype1diabetesinyoungchildrenaged4to10years
AT beckroy extended6monthfollowupofarandomizedclinicaltrialtoassesstheefficacyandsafetyofrealtimecontinuousglucosemonitoringinthemanagementoftype1diabetesinyoungchildrenaged4to10years
AT ruedykatrina extended6monthfollowupofarandomizedclinicaltrialtoassesstheefficacyandsafetyofrealtimecontinuousglucosemonitoringinthemanagementoftype1diabetesinyoungchildrenaged4to10years
AT chengpeiyao extended6monthfollowupofarandomizedclinicaltrialtoassesstheefficacyandsafetyofrealtimecontinuousglucosemonitoringinthemanagementoftype1diabetesinyoungchildrenaged4to10years
AT tamborlanewilliam extended6monthfollowupofarandomizedclinicaltrialtoassesstheefficacyandsafetyofrealtimecontinuousglucosemonitoringinthemanagementoftype1diabetesinyoungchildrenaged4to10years
AT kollmancraig extended6monthfollowupofarandomizedclinicaltrialtoassesstheefficacyandsafetyofrealtimecontinuousglucosemonitoringinthemanagementoftype1diabetesinyoungchildrenaged4to10years
AT maurasnelly extended6monthfollowupofarandomizedclinicaltrialtoassesstheefficacyandsafetyofrealtimecontinuousglucosemonitoringinthemanagementoftype1diabetesinyoungchildrenaged4to10years
AT foxlarry extended6monthfollowupofarandomizedclinicaltrialtoassesstheefficacyandsafetyofrealtimecontinuousglucosemonitoringinthemanagementoftype1diabetesinyoungchildrenaged4to10years
AT coffeyjulie extended6monthfollowupofarandomizedclinicaltrialtoassesstheefficacyandsafetyofrealtimecontinuousglucosemonitoringinthemanagementoftype1diabetesinyoungchildrenaged4to10years
AT whiteneilh extended6monthfollowupofarandomizedclinicaltrialtoassesstheefficacyandsafetyofrealtimecontinuousglucosemonitoringinthemanagementoftype1diabetesinyoungchildrenaged4to10years
AT extended6monthfollowupofarandomizedclinicaltrialtoassesstheefficacyandsafetyofrealtimecontinuousglucosemonitoringinthemanagementoftype1diabetesinyoungchildrenaged4to10years